✦ LIBER ✦

2009 Interstitial implantation as a radiation boost for high risk patients treated with breast conservation therapy

✍ Scribed by Bradley Kramer; David E. Wazer; Christopher Schmid; Kenneth Ulin; Rupert Schmidt-Ullrich

Book ID: 108436992
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 130 KB
Volume: 36
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(97)85588-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

127 Interstitial high-dose-rate brachyth

127 Interstitial high-dose-rate brachytherapy as a method of boost in breast conservative therapy for patients with close to positive margins

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Morphologic Risk Factors for Local Recur

Morphologic Risk Factors for Local Recurrence in Patients with Invasive Breast Cancer Treated with Conservative Surgery and Radiation Therapy

✍ Stuart J. Schnitt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Late Toxicity and Cosmetic Outcome in Pa

Late Toxicity and Cosmetic Outcome in Patients With Breast Cancer Treated With Intraoperative Radiation Therapy as an Electron Boost

✍ Govers, M.; Weytjens, R.; Erven, K.; van Dam, P.; Van Laere, S.; Prové, A.; Albe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

5-Year Results of Pulsed Dose Rate Brach

5-Year Results of Pulsed Dose Rate Brachytherapy Applied as a Boost after Breast-Conserving Therapy in Patients at High Risk for Local Recurrence from Breast Cancer

✍ Wolfgang Harms; Robert Krempien; Frank W. Hensley; Christiane Berns; Peter Fritz 📂 Article 📅 2002 🏛 Springer 🌐 German ⚖ 160 KB

A randomized trial of long term adjuvant

A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery

✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w

77 Impact of high-dose-rate brachytherap

77 Impact of high-dose-rate brachytherapy as a method of boost in breast conservative therapy for patients with close to positive margins

✍ M. Jolicoeur; M-L. Doiron-Racine; A. Devieux; C. Lambert; B. Fortin; T-V. Nguyen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 238 KB